Anika Therapeutics (ANIK) Amortizatization of Intangibles (2019 - 2026)
Anika Therapeutics has reported Amortizatization of Intangibles over the past 8 years, most recently at $464000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 122.01% to $464000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Mar 2026, up 107.34% year-over-year, with the annual reading at $2.1 million for FY2025, 66.61% up from the prior year.
- Amortizatization of Intangibles was $464000.0 for Q1 2026 at Anika Therapeutics, down from $1.7 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $6.1 million in Q4 2023 and troughed at -$1.1 million in Q2 2022.
- The 5-year median for Amortizatization of Intangibles is $547000.0 (2023), against an average of $1.1 million.
- The largest YoY upside for Amortizatization of Intangibles was 625.93% in 2025 against a maximum downside of 221.16% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.9 million in 2022, then soared by 216.03% to $6.1 million in 2023, then tumbled by 105.27% to -$324000.0 in 2024, then surged by 625.93% to $1.7 million in 2025, then plummeted by 72.77% to $464000.0 in 2026.
- Per Business Quant, the three most recent readings for ANIK's Amortizatization of Intangibles are $464000.0 (Q1 2026), $1.7 million (Q4 2025), and -$710000.0 (Q3 2025).